Literature DB >> 11996618

Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.

Eric M Mortensen1, Christopher M Coley, Daniel E Singer, Thomas J Marrie, D Scott Obrosky, Wishwa N Kapoor, Michael J Fine.   

Abstract

BACKGROUND: To our knowledge, no previous study has systematically examined pneumonia-related and pneumonia-unrelated mortality. This study was performed to identify the cause(s) of death and to compare the timing and risk factors associated with pneumonia-related and pneumonia-unrelated mortality.
METHODS: For all deaths within 90 days of presentation, a synopsis of all events preceding death was independently reviewed by 2 members of a 5-member review panel (C.M.C., D.E.S., T.J.M., W.N.K., and M.J.F.). The underlying and immediate causes of death and whether pneumonia had a major, a minor, or no apparent role in the death were determined using consensus. Death was defined as pneumonia related if pneumonia was the underlying or immediate cause of death or played a major role in the cause of death. Competing-risk Cox proportional hazards regression models were used to identify baseline characteristics associated with mortality.
RESULTS: Patients (944 outpatients and 1343 inpatients) with clinical and radiographic evidence of pneumonia were enrolled, and 208 (9%) died by 90 days. The most frequent immediate causes of death were respiratory failure (38%), cardiac conditions (13%), and infectious conditions (11%); the most frequent underlying causes of death were neurological conditions (29%), malignancies (24%), and cardiac conditions (14%). Mortality was pneumonia related in 110 (53%) of the 208 deaths. Pneumonia-related deaths were 7.7 times more likely to occur within 30 days of presentation compared with pneumonia-unrelated deaths. Factors independently associated with pneumonia-related mortality were hypothermia, altered mental status, elevated serum urea nitrogen level, chronic liver disease, leukopenia, and hypoxemia. Factors independently associated with pneumonia-unrelated mortality were dementia, immunosuppression, active cancer, systolic hypotension, male sex, and multilobar pulmonary infiltrates. Increasing age and evidence of aspiration were independent predictors of both types of mortality.
CONCLUSIONS: For patients with community-acquired pneumonia, only half of all deaths are attributable to their acute illness. Differences in the timing of death and risk factors for mortality suggest that future studies of community-acquired pneumonia should differentiate all-cause and pneumonia-related mortality.

Entities:  

Mesh:

Year:  2002        PMID: 11996618     DOI: 10.1001/archinte.162.9.1059

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  113 in total

1.  Severity assessment for lower respiratory tract infections: potential use and validity of the CRB-65 in primary care.

Authors:  Nick A Francis; Jochen W Cals; Christopher C Butler; Kerenza Hood; Theo Verheij; Paul Little; Herman Goossens; Samuel Coenen
Journal:  Prim Care Respir J       Date:  2012-03

2.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

3.  A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Authors:  Marco Falcone; Alessandro Russo; Yuichiro Shindo; Alessio Farcomeni; Filippo Pieralli; Roberto Cangemi; Jinliang Liu; Jingyan Xia; Junya Okumura; Masahiro Sano; Christopher Jones; Vieri Vannucchi; Massimo Mancone; Scott Micek; Feng Xu; Francesco Violi; Marin Kollef
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

4.  Statins and outcomes in patients with pneumonia: not only healthy user bias.

Authors:  Eric M Mortensen; Marcos I Restrepo; Laurel A Copeland; Mary Jo V Pugh; Antonio Anzueto
Journal:  BMJ       Date:  2006-11-25

5.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

6.  Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.

Authors:  Zoe Athanassa; Gregory Makris; George Dimopoulos; Matthew E Falagas
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  In-Hospital Deaths Among Adults With Community-Acquired Pneumonia.

Authors:  Grant W Waterer; Wesley H Self; D Mark Courtney; Carlos G Grijalva; Robert A Balk; Timothy D Girard; Sherene S Fakhran; Christopher Trabue; Paul McNabb; Evan J Anderson; Derek J Williams; Anna M Bramley; Seema Jain; Kathryn M Edwards; Richard G Wunderink
Journal:  Chest       Date:  2018-05-30       Impact factor: 9.410

Review 8.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

Review 9.  Defining and predicting severe community-acquired pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Curr Opin Infect Dis       Date:  2010-04       Impact factor: 4.915

10.  Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia.

Authors:  Samuel M Brown; Barbara E Jones; Al R Jephson; Nathan C Dean
Journal:  Crit Care Med       Date:  2009-12       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.